Evidence map›Paper›PMID 41697249›Full record

ArticleeLife2026

Prediction of SARS-CoV-2 transmission dynamics based on population-level cycle threshold values: An epidemic transmission and machine learning modeling study.

Afraz Arif Khan, Hind Sbihi, Michael A Irvine, Agatha N Jassem, Yayuk Joffres, Braeden Klaver, Naveed Janjua, Aamir Bharmal, Carmen H Ng, Chris D Fjell and 10 more

Abstract read
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Afraz Arif KhanBritish Columbia Centre for Disease Control, Vancouver, Canada.ORCID https://orcid.org/0000-0002-5545-2851
Hind SbihiBritish Columbia Centre for Disease Control, Vancouver, Canada.
Michael A IrvineBritish Columbia Centre for Disease Control, Vancouver, Canada.
Agatha N JassemBritish Columbia Centre for Disease Control, Vancouver, Canada.
Yayuk JoffresBritish Columbia Centre for Disease Control, Vancouver, Canada.
Braeden KlaverBritish Columbia Centre for Disease Control, Vancouver, Canada.
Naveed JanjuaBritish Columbia Centre for Disease Control, Vancouver, Canada.
Aamir BharmalSchool of Population and Public Health, University of British Columbia, Vancouver, Canada.
Carmen H NgOffice of the Medical Health Officer, Fraser Health, Surrey, Canada.
Chris D FjellBritish Columbia Centre for Disease Control, Vancouver, Canada.
Miguel ImperialLifeLabs, Surrey, Canada.ORCID https://orcid.org/0000-0002-4061-7940
Susan RomanFraser Health, Surrey, Canada.
Marthe K CharlesDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Amanda WilmerDivision of Medical Microbiology, Kelowna General Hospital, Kelowna, Canada.
John GalbraithDivision of Microbiology and Molecular Diagnostics, Victoria General Hospital, Victoria, Canada.
Marc G RomneyDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Bonnie HenryMinistry of Health, Victoria, Canada.
Linda M N HoangBritish Columbia Centre for Disease Control, Vancouver, Canada.
Mel KrajdenBritish Columbia Centre for Disease Control, Vancouver, Canada.
Catherine A HoganBritish Columbia Centre for Disease Control, Vancouver, Canada.ORCID https://orcid.org/0000-0003-1977-253X

Funding

BCCDC Foundation for Public Health Public Health Rapid SARS-CoV-2 Vaccine Research Initiative in BCGenome British Columbia Public Health Rapid SARS-CoV-2 Vaccine Research Initiative in BCMichael Smith Health Research BC Public Health Rapid SARS-CoV-2 Vaccine Research Initiative in BCPublic Health Agency of Canada 2021-HQ-000120
6 · The paper itself

Abstract

Polymerase chain reaction (PCR) cycle threshold (Ct) values can be used to estimate the viral burden of Severe Acute Respiratory Syndrome Coronavirus type 2 (SARS-CoV-2) and predict population-level epidemic trends. We investigated the use of epidemic transmission modeling and machine learning (ML) based on Ct value distribution for SARS-CoV-2 incidence prediction in British Columbia, Canada, during an Omicron subvariant BA.1-predominant period from November 2021 to January 2022. Using real-world data, we developed an epidemic transmission model that was first validated on outbreak data and subsequently fitted to province-level data to predict incidence. Using simulated data, we developed a ML pipeline including five models to predict the reproductive number as a measure of transmission potential based on Ct value distribution and validated it on out-of-sample province-level data. The epidemic transmission model demonstrated accurate prediction with the real incidence falling within the 95% credible interval of the predicted MCMC chains for both the long-term care facility outbreak and province-level data. The ML models demonstrated good performance with a mean squared error (MSE) lower than 0.17 across all models and improved performance with increasing sample size. The variability of the Ct distribution around the mean was the strongest predictor of the reproductive number. These modeling approaches demonstrated utility for incidence and reproductive number prediction and have potential to complement traditional surveillance in real time to guide public health interventions.

Indexed as

COVID-19Machine LearningSARS-CoV-2British ColumbiaEpidemiological ModelsHumansIncidencePredictive Learning Modelscycle thresholdepidemiologyglobal healthnonepublic healthSARS-CoV-2testingtransmissionviral load

Identifiers

PMID41697249
PMCPMC13155751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.